Literature DB >> 6823205

Amperometric detection of low concentrations of dopamine receptor agonists after liquid chromatographic on-column sample enrichment: effect of o-methylation on brain concentrations of dipropyl-5,6-ADTN and dipropyl-6,7-ADTN.

M G Feenstra, H Rollema, T B Mulder, B H Westerink, A S Horn.   

Abstract

A sensitive and selective method of determination of N,N-dipropylamino-5, 6-dihydroxytetralin and its 6,7-dihydroxy isomer in rat plasma and brain tissue is described. The method is based on isolation of these dopamine receptor agonists from the biological samples on small Sephadex G-10 columns, followed by reversed phase high performance liquid chromatography with amperometric detection. Large volume (2 ml) injections result in on-column sample enrichment without a subsequent loss in column efficiency. Using this method the very low detection limit of 4 pmol/g was achieved in brain tissue. It was found that the lower in vivo potency as a centrally acting dopamine agonist of the 6,7-compared with the 5,6-isomer is almost entirely due to the lower brain concentrations achieved after peripheral administration of equimolar doses. This difference is mainly caused by different rates of O-methylation by catechol-O-methyltransferase, which follows from the fact that inhibition of this enzyme by tropolone leads to almost equal brain concentrations of the two isomers.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6823205     DOI: 10.1016/0024-3205(83)90138-8

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  2 in total

1.  Inhibition of rat brain monoamine oxidase type A by 2-aminotetralin and tetrahydroisoquinoline analogues of dopamine.

Authors:  M G Feenstra; T van der Velden; D Dijkstra; O R Hommes; A S Horn
Journal:  Pharm Weekbl Sci       Date:  1983-08-26

2.  Brain and serum concentrations of dopamine analogues after peripheral administration to rats.

Authors:  M G Feenstra; J W Homan; R Everts; H Rollema; A S Horn
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-06       Impact factor: 3.000

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.